Intellia

Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Gene Editing
CRISPR Technology
Cell Engineering
Bioinformatics
Drug Development
Intellia在招职位
0个在招职位
目前没有在招职位
已关闭职位
4个职位
Our Culture
Remote
已关闭 6个月前
ONE Intellia
Remote
已关闭 6个月前
Join Us
Remote
已关闭 6个月前
Careers
Remote
已关闭 6个月前
产品与服务
CR
CRISPR/Cas9 Gene Editing Platform
Gene Editing Technology
NT
NTLA-2001
Gene Editing Therapy
NT
NTLA-3001
Gene Editing Therapy
EX
Ex Vivo Cell Engineering
Cell Engineering Service
NT
NTLA-2002
Gene Editing Therapy
NE
Neurological Disease Programs
Gene Editing Therapy
PR
Primary Hyperoxaluria Program
Gene Editing Therapy
MO
Modular CRISPR Platform
Platform Technology
AS
ASGR1 Program
Gene Editing Therapy
IN
In Vivo Gene Editing Services
Gene Editing Service
LI
Lipid Nanoparticle Delivery System
Drug Delivery Technology

NTLA-5001
Cell Therapy
IM
Immunology Pipeline
Therapeutic Pipeline

NTLA-2003
Gene Editing Therapy

Asgard Platform
Platform Technology
LI
Lipid Nanoparticle Platform
Technology Platform
ON
Oncology Cell Therapies
Cell Therapy

Engineered Cell Medicines
Cell Therapy
CR
CRISPR Platform Technology
Technology Platform
相似公司

Insulet
A father’s determination to free his son from the burden of daily insulin injections was the driving force that created Insulet in 2000.
Bedford, Massachusetts, United States
501-1,000人
Public
估值 $2.1B
104个在招职位

CRISPR Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in…
Zug, Canton of Zug
201-500人
Public
估值 $2.9B
13个在招职位

Mammoth Biosciences
Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are…
Brisbane, San Mateo County
51-200人
Private
估值 $800M
Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for…
Cambridge, Middlesex County
5,001-10,000人
Public
估值 $16.2B
340个在招职位

Xaira
AI for drug discovery
San Francisco, CA
51-200人
Private
估值 2.1B
最新动态
All
X
News
HN
YouTube
H.C. Wainwright reiterates Intellia stock rating on FDA review progress - Investing.com
Investing.com
News
·
今天
Citizens reiterates Intellia stock rating on FDA priority review - Investing.com
Investing.com
News
·
今天
Intellia's 'Lonvo-Z' Enters FDA Priority Review — Bids to Become World's First In Vivo CRISPR Therapy - finance.biggo.com
finance.biggo.com
News
·
今天
Intellia Announces FDA Acceptance of BLA for Lonvo-z with PDUFA Date March 10, 2027 - TradingView
TradingView
News
·
昨天
Intellia’s one-shot CRISPR therapy gets March 2027 FDA decision date - allsci.com
allsci.com
News
·
昨天
更多 (剩余15条)
浏览量
4
申请点击
0
模拟申请
0
收藏
0
评价
2.7
2条评价
工作生活平衡
3.0
薪酬
3.0
企业文化
2.0
职业发展
2.5
管理层
1.5
25%
推荐率
优点
Potential for meaningful medical impact
Working on innovative treatments
Opportunity to help patients with rare diseases
缺点
Poor management decisions
Unfair layoff practices
Favoritism in promotions
薪资范围
47个数据点
Mid/L4
1份报告
-
年薪总额
基本工资
$165,000
股票
-
联系方式与地址